We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
(+6.5%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$905M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$585M |
| 3 |
Cisco
CSCO
|
+$554M |
| 4 |
International Flavors & Fragrances
IFF
|
+$456M |
| 5 |
Mastercard
MA
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
DuPont de Nemours
DD
|
+$556M |
| 3 |
Qualcomm
QCOM
|
+$405M |
| 4 |
Merck
MRK
|
+$333M |
| 5 |
TSMC
TSM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.54% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Rafael Holdings
RFL
$107M
| $1.72M | ﹤0.01% |
43,562
+5,974
| +16% | +$194K |
|
2652
Atomera
ATOM
$214M
| $1.71M | ﹤0.01% |
69,616
-314
| -0.4% | -$9.19K |
|
2653
China Yuchai International
CYD
$1.78B
| $1.71M | ﹤0.01% |
110,103
-3,896
| -3% | -$64.9K |
|
2654
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $1.7M | ﹤0.01% |
91,943
-337,060
| -79% | -$6.89M |
|
2655
OneWater Marine
ONEW
$201M
| $1.7M | ﹤0.01% |
42,594
+10,974
| +35% | +$398K |
|
|
TECX
2656
Tectonic Therapeutic
TECX
$606M
| $1.7M | ﹤0.01% |
11,154
-1,274
| -10% | -$207K |
|
|
GSKY
2657
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $1.69M | ﹤0.01% |
272,745
-15,329
| -5% | -$87.9K |
|
2658
Fulcrum Therapeutics
FULC
$297M
| $1.69M | ﹤0.01% |
143,202
+25,448
| +22% | +$315K |
|
2659
Napco Security Technologies
NSSC
$1.48B
| $1.68M | ﹤0.01% |
96,490
+4,054
| +4% | +$62.5K |
|
|
OLP
2660
One Liberty Properties
OLP
$527M
| $1.67M | ﹤0.01% |
75,130
-1,456
| -2% | -$31.4K |
|
2661
ANI Pharmaceuticals
ANIP
$1.78B
| $1.67M | ﹤0.01% |
46,190
+3,922
| +9% | +$123K |
|
2662
Team
TISI
$77.7M
| $1.66M | ﹤0.01% |
14,393
-150
| -1% | -$16.4K |
|
2663
Intrepid Potash
IPI
$469M
| $1.66M | ﹤0.01% |
50,917
-4,467
| -8% | -$132K |
|
2664
Minerva Neurosciences
NERV
$199M
| $1.65M | ﹤0.01% |
15,335
-406
| -3% | -$10.1K |
|
2665
Shattuck Labs
STTK
$694M
| $1.65M | ﹤0.01% |
56,413
+1,209
| +2% | +$50.8K |
|
|
AKTS
2666
DELISTED
Akoustis Technologies Inc
AKTS
| $1.65M | ﹤0.01% |
123,630
+11,347
| +10% | +$165K |
|
2667
Allient
ALNT
$1.92B
| $1.64M | ﹤0.01% |
47,870
-2,380
| -5% | -$78.6K |
|
|
GOCO
2668
DELISTED
GoHealth
GOCO
| $1.64M | ﹤0.01% |
9,336
-155
| -2% | -$31.3K |
|
|
CBAY
2669
DELISTED
Cymabay Therapeutics
CBAY
| $1.64M | ﹤0.01% |
360,578
+33,867
| +10% | +$182K |
|
2670
Sierra Bancorp
BSRR
$525M
| $1.63M | ﹤0.01% |
60,818
-307
| -0.5% | -$7.72K |
|
2671
Savara
SVRA
$1.19B
| $1.63M | ﹤0.01% |
+154,027
| New | +$264K |
|
2672
Universal Logistics Holdings
ULH
$529M
| $1.62M | ﹤0.01% |
61,688
-1,789
| -3% | -$42.9K |
|
2673
Dianthus Therapeutics
DNTH
$6.09B
| $1.62M | ﹤0.01% |
8,563
-416
| -5% | -$70K |
|
2674
Prelude Therapeutics
PRLD
$390M
| $1.62M | ﹤0.01% |
37,346
+2,624
| +8% | +$174K |
|
2675
FRP Holdings
FRPH
$421M
| $1.62M | ﹤0.01% |
65,728
-1,106
| -2% | -$26.1K |
|
Similar funds
VFT
Nuveen's Q1 2021 Portfolio in Review
As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
- Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
- Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
- Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
- Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
- Nuveen opened 118 new positions and closed 82 in Q1 2021.
- Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.
Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.